E-ISSN: 1308-5263
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report [Turk J Hematol]
Turk J Hematol. 2024; 41(1): 61-63 | DOI: 10.4274/tjh.galenos.2024.2023.0477  

Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report

Yu-han Gao, Ming-hui Duan, Jian Li, Lu Zhang
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Keywords: Idiopathic multicentric Castleman disease, Janus kinase inhibitor, Ruxolitinib, Treatment


Refrakter İdiyopatik Multisentrik Castleman Hastalığının Tedavisinde Ruxolitinib: Bir Olgu Sunumu

Yu-han Gao, Ming-hui Duan, Jian Li, Lu Zhang
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China

Anahtar Kelimeler: İdiyopatik multisentrik Castleman hastalığı, Janus kinaz inhibitörü, Ruxolitinib, Tedavi


Yu-han Gao, Ming-hui Duan, Jian Li, Lu Zhang. Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report. Turk J Hematol. 2024; 41(1): 61-63

Corresponding Author: Yu-han Gao, China


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar